Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Evoq Remedies Ltd has notified BSE that its Board of Directors meeting originally scheduled for 14th May 2026 has been rescheduled to 27th May 2026 at 4:00 PM at the company's registered office in Ahmedabad. The meeting will consider and approve the Audited Financial Results for the half year and full year ended 31st March 2026, along with the Auditor's Report. The filing was made on 11th May 2026 under SEBI LODR Regulation 29(1). This is a routine regulatory intimation to inform the stock exchange of the change in meeting date. No financial details or performance indicators are disclosed in this filing.
This is a procedural filing and does not directly impact shareholders. The rescheduling delays the release of FY2026 audited financial results by two weeks. Investors should note the new date (27th May 2026) for when financial results will be announced.